"The U.S. Food and Drug Administration today approved Lymphoseek (technetium Tc 99m tilmanocept) Injection, a radioactive diagnostic imaging agent that helps doctors locate lymph nodes in patients with breast cancer or melanoma who are undergoing "...
Vinblastine Sulfate Consumer
IMPORTANT: HOW TO USE THIS INFORMATION: This is a summary and does NOT have all possible information about this product. This information does not assure that this product is safe, effective, or appropriate for you. This information is not individual medical advice and does not substitute for the advice of your health care professional. Always ask your health care professional for complete information about this product and your specific health needs.
VINBLASTINE - INJECTION
COMMON BRAND NAME(S): Velban
WARNING: If vinblastine accidentally leaks into tissue around the injection site, the skin and/or muscle may be severely damaged. Tell your doctor immediately if you feel pain or irritation at the injection site. This drug is injected into a vein only. This medication must not be injected under the skin, into a muscle, or into the spine.
Deaths have occurred when vinblastine was injected into the spine. This medication should be clearly labeled for injection into a vein only. To prevent accidental injection into the spine, do not remove the syringe from its labeled outside cover until immediately before use.
USES: Vinblastine is used to treat cancer. It works by slowing or stopping the growth of cancer cells.
HOW TO USE: This medication is given by injection into a vein by a health care professional. It is usually given once a week or as directed by your doctor. To prevent leakage of the medication into tissue around the vein, vinblastine should be injected over 1 minute. Tell your health care professional immediately if you experience pain, burning, or redness at the injection site. This medication should not be mixed in a large amount of solution and/or injected over a long time (such as 30 to 60 minutes) unless directed by your doctor. Doing so may increase the risk of leakage. If the medication starts to leak into tissue, the injection should be stopped and the remaining solution should be given into a different vein.
The dosage is based on your medical condition, body size, and response to treatment. Your doctor will do blood tests (complete blood count) to find the right dose for you. Your next dose may need to be rescheduled if your white blood cell count is too low.
Avoid getting this medication in your eye. If this occurs, wash the affected eye(s) well and contact your doctor.
Unless your doctor instructs you otherwise, drink plenty of fluids while taking this medication. Doing so helps your kidneys to remove the drug from your body and avoid some of the side effects.
Additional Vinblastine Sulfate Information
- Vinblastine Sulfate Drug Interactions Center: vinblastine iv
- Vinblastine Sulfate Side Effects Center
- Vinblastine Sulfate Overview including Precautions
- Vinblastine Sulfate FDA Approved Prescribing Information including Dosage
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get the latest treatment options.